Učitavanje...
Future prospects for contact factors as therapeutic targets
Anticoagulants currently used in clinical practice to treat or prevent thromboembolic disease are effective, but place patients at increased risk for serious bleeding because they interfere with plasma enzymes (thrombin and factor Xa) that are essential for hemostasis. In the past 10 years, work wit...
Spremljeno u:
| Izdano u: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4364029/ https://ncbi.nlm.nih.gov/pubmed/25696834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/asheducation-2014.1.52 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|